Corinna Albers-Leischner

Corinna Albers-Leischner is a researcher at the University Cancer Center Hamburg (UCCH), affiliated with the Faculty of Medicine at the University of Hamburg. Her work focuses on molecular oncology, particularly in lung cancer, leukemia, and lymphoma.

Research Interests: Her primary research areas include Oncology, Molecular Biology, and Cancer Genetics, with specific expertise in EGFR mutations, JAK2 inhibitor resistance, BCR-ABL signaling pathways, and lymphomagenesis mechanisms. Her work bridges basic molecular research and clinical applications in targeted cancer therapies.

Publication Trends: Analysis of her 13 publications (2010-2024) reveals a strong emphasis on molecular mechanisms of drug resistance in hematological malignancies and solid tumors. Her recent work (2022-2024) focuses on real-world clinical outcomes in lung cancer with EGFR mutations and novel resistance mechanisms in kinase inhibitors, demonstrating translational impact from bench to bedside.

Collaborations: She actively collaborates with major German cancer research networks including the German National Network Genomic Medicine Lung Cancer (nNGM) and works within multidisciplinary teams at UCCH focusing on precision oncology approaches.